RenovoRx, Inc. (RNXT) vs XBiotech Inc. (XBIT)
A side-by-side comparison of RenovoRx, Inc. and XBiotech Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
RNXT
RenovoRx, Inc.
$1.40HealthcareDelayed quote: Oct 6, 2026, 2:15 PM EDT
XBIT
XBiotech Inc.
$2.16HealthcareDelayed quote: Oct 6, 2026, 2:14 PM EDT
Total return — RNXT vs XBIT
growth of $100 · dividends reinvested · last 5yRNXT -79.8% (-27.3%/yr)XBIT -86.3% (-32.8%/yr)RNXT compounded faster over this window
RNXT XBIT
RNXT vs XBIT: by the numbers
- •XBIT is the larger company ($66M vs $63M market cap).
- •Both run net losses; XBIT's is the smaller (0.00% vs -621.71% net margin).
Metrics side by side
Valuation
| Metric | RNXT | XBIT |
|---|---|---|
| P/S ratio | 31.81 | N/A |
| P/B ratio | 7.00 | 0.51 |
Profitability
| Metric | RNXT | XBIT |
|---|---|---|
| Gross margin | 70.88% | 0.00% |
| Operating margin | -1113.98% | 0.00% |
| Net margin | -621.71% | 0.00% |
| ROE | -136.82% | -35.13% |
| ROIC | -139.74% | -37.01% |
Growth (annualized)
| Metric | RNXT | XBIT |
|---|---|---|
| Total return CAGR (5Y) | -23.80% | -29.36% |
Frequently asked
- How have RNXT and XBIT total returns compared?
- Over the past 5 years, RNXT delivered -23.80% and XBIT delivered -29.36% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.